Armo raises $67M series C-1 round

Armo BioSciences Inc. (Redwood City, Calif.) raised $67 million in an untranched series C-1 round led by Qiming Venture Partners.

Fellow new investors Decheng Capital, Sequoia Capital, Quan Capital and RTW Investments also participated, along with existing investors Kleiner Perkins Caufield & Byers, OrbiMed Advisors, DAG Ventures, NanoDimension, HBM Healthcare Investments, GV, Celgene Corp. (NASDAQ:CELG) and funds advised by Clough Capital...